Onyeachonam FIO*

Department of Veterinary Biochemistry and Animal Production, College of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, Nigeria

*Corresponding Author: Onyeachonam FIO, Department of Veterinary Biochemistry and Animal Production, College of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, Nigeria.

Received: July 18, 2022; Published: August 19, 2022

Abstract

Molecules of Aluminum-magnesium silicate (AMS), a solid mineral approved as medicine by WHO, consist of Nanoparticles (0.96 nm) that are smaller than viruses (≥ 5 nm). The Nanoparticles have positively and negatively charged ends while RNA viruses are positively charged with DNA viruses and abnormal (tumor/infected) cells, negatively charged whereas normal cells remain neutral. So, AMS-Nanoparticles mop viruses and abnormal cells by opposite charges electrostatic attraction. Presence of the two charges makes AMS` Nanoparticles hydrate in solutions to stabilize (potentiate) other medicines formulated with it. Some countries lack AMS-deposits. So, Aluminum silicate and Magnesium silicate (WHO-approved medicines, too) were used to formulate AMS-brand, named Medicinal synthetic AMS (MSAMS; Antivirt^®; VITUMED^®). To make the un-absorbable MSAMS act systemically, Dextrose monohydrate (simple sugar) is incorporated in its formulations to convey the electrically charged Nanoparticles into blood-circulation by the active-transport principle. These mechanisms confer on MSAMS the Antiviral; Antitumor; Adjuvant efficacies being reviewed.

Keywords: MSAMS; Adjuvant Efficacy; Anti-tumor Efficacy; Antiviral Efficacy

References

1. Brooks GF. “Medical Microbiology”. 21 Edn., McGRAW, San Francisco, USA (1998).
2. Ezeibe MCO. “Peer review-proofs for Antiviral, Antitumor and Adjuvant Efficacies of Medicinal synthetic Aluminum-magnesium silicate {Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂ Mg₃ (SiO₄)₃}”. harmoneyartworld123@gmail.com. (2022).
3. Vanderbilt RT. “Veegum-The versatile ingredient for pharmaceutical formulations”. Inc. Technical Literature (2012).
4. Chen BD., et al. “Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes”. Theranostics 6 (2016): 1887-1898.
5. Suni L., et al. “Immunostimulation by Silica Particles and the Development of Autoimmune Dysregulation”. InTech .Open, London (2014).
6. Brent W., et al. “What Do We Really Know about Antibiotics Pharmacodynamics?” Pharmcotherapy 21(2001): 28-31.
7. Ezeibe MCO. “Medicinal synthetic Aluminum-magnesium silicate (Nanoparticles)-Antiviral agent and adjuvant to chemotherapeutics”. Federal Republic of Nigeria Patents and Designs Ref No.: NG/P/2012/639.
8. Ezeibe , et al. “Assessment of Antiretroviral effects of a synthetic Aluminum-magnesium silicate”. BJMMR 4.8(2014): 1672-1679.
9. Ezeibe MCO and Ogbonna IJ. “In vivo Antiretroviral Effects of the Medicinal Synthetic Aluminum-Magnesium Silicate”. World Journal of AIDS 5(2015): 59-65.
10. Ezeibe MCO and Ogbonna IJ. “Medicinal synthetic Aluminum-magnesium silicate {Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂Mg₃ (SiO₄)₃}-A highly active anti-retroviral medicine”. World Journal of AIDS 6 (2016): 42-46.
11. Ezeibe MCO., et al. “Effective Treatment of HIV/AIDS with the Medicinal Synthetic Aluminum-Magnesium Silicate: {Al₄(SiO₄)₃ + 3Mg₂SiO₄→2Al₂Mg₃(SiO₄)₃}”. SF AIDS HIV Research 1 (2017):
12. Ezeibe MCO., et al. “Medicinal synthetic Aluminum-magnesium silicate {Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂ Mg₃ (SiO₄)₃} normalizes immunity and terminates HIV-infections”. Journal of Retro Virology and Anti-Retro Virology (2019).
13. Ezeibe MCO., et al. “Cure for HIV/AIDS with Medicinal synthetic Aluminum-magnesium silicate {Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂ Mg₃ (SiO₄)₃}-A case report”. World Journal of AIDS3 (2019): 161-166.
14. Ezeibe MCO., et al. “Electrostatic-Mopping of Viruses with Medicinal Synthetic Aluminum-Magnesium Silicate {Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂ Mg₃ (SiO₄)₃}, for Quick-Cure of COVID-19: A Better Control-Measure OJEpi”. 11.3 (2021): 278-383.
15. Ezeibe MCO., et al. “Antiviral Effects of a synthetic Aluminum-magnesium silicate on Avian Influenza Virus”. Health 7 (2012): 429-432.
16. Ezeibe MCO., et al. “Effects of Aluminium-Magnesium Silicate on Newcastle disease virus and on recovery of infected chicks”. International Journal of Biological and Chemical Sciences 2 (2016): 825-829.
17. Ezeibe MCO., et al. “In vitro and in vivo effects of Aluminum-magnesium silicate on Infectious bursa disease virus in chicken”. Animal Science Reports 4 (2009): 132-137.
18. Ezeibe MCO., et al. “Haemagglutination-inhibition and Haemagglutination titres of Egg drop syndrome 76 virus treated with Aluminum-magnesium silicate”. Animal Science Reports 3 (2010): 87-90.
19. Ezeibe MCO., et al. “Aluminum-magnesium silicate enhances release of virions of cultured Fowl pox Virus and inhibits the virus”. Health9 (2013): 1394-1396.
20. Ezeibe MCO., et al. “Antiviral effects of Aluminum-magnesium silicate on Peste des Petits Ruminants Virus”. Animal Science Reports 4 (2009): 141-147.
21. Ezeibe , et al. “Aluminum-magnesium silicate inhibits canine parvovirus and cures infected dogs”. Health 2.10 (2010): 1215-1217.
22. Cristina E., et al. “Nanomaterials and nanoparticles: Sources and toxicity”. Biointerphases 2 (2007): MR17-MR71.
23. Ezeibe MCO., et al. “Efficacy of Piparazine Citrate, stabilized with Aluminum-magnesium silicate, against Helignosomoides bakeri”. Health 4.10 (2012): 890-892.
24. Ezeibe , et al. “Antibiotic activity of Ampicillin trihydrate formulated in Aluminum-magnesium silicate, against Salmonella gallinarum”. Health 4.9 (2012): 675-678.
25. Ezeibe MCO., et al. “Synergy in antibacterial activities of Ampicillin trihydrate, stabilized with a synthetic Aluminum-magnesium silicate and immune-stimulants, on resistant Escherichia coli infection”. Health10 (2013): 1548-1552.
26. Ezeibe MCO. “Studies of effects of Aluminum-magnesium silicate and B-vitamins on actions of Chloroquin, for treatment of plasmodium infections, with mice as models (FCVSN thesis)” (2015).
27. Ezeibe , et al. “Effect of Aluminum-magnesium silicate on anticcocidial activity of Sulphadimidine”. Tropical Veterinarian 29 (2011): 41-44.
28. Ezeibe MCO., et al. “Effective treatment of resistant Escherichia coli infection, with Sulphadimidine stabilized in a synthetic Aluminum-magnesium silicate”. Health12 (2012): 1295-1298.
29. Ezeibe MCO., et al. “Restoring efficacy to cotrimoxazole against resistant Salmonella pullorum with Medicinal synthetic Aluminum-magnesium silicate: Al₄ (SiO₄)₃ + 3Mg₂SiO₄ →2Al₂ Mg₃ (SiO₄)₃]”. Health 9 (2019): 1162-1168.
30. Ezeibe MCO., et al. “Regression of Symptoms of Trypanosomosis in Mice treated with Cotrimoxazole-Antivirt^® {Al₄ (Si O₄)₃ + 3Mg₂ SiO₄ → Al₂ Mg₃ (SiO₄)₃} Formulation". Acta Scientific Veterinary Sciences 2 (2020): 23-28.
31. Ezeibe MCO., et al. “Antivirt ^®{Al₄ (SiO₄)₃ + 3Mg₂SiO₄ → 2Al₂ Mg₃ (SiO₄)₃} enhances efficacy of Co-trimoxazole to terminate experimental Trypanosome-infections in mice”. Global Journal of Medical Research: (G) Veterinary Science and Veterinary Medicine 3 (2020): 10-19.

Citation

Citation: Onyeachonam FIO. “Efficacies of the Medicinal Synthetic Aluminum-magnesium Silicate: A Review". Acta Scientific Pharmaceutical Sciences 6.9 (2022): 10-16.

Copyright

Copyright: © 2022 Onyeachonam FIO. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.